IRF4 dysregulation in chronic myelomonocytic leukemia: another brick in the wall of myelodysplastic/myeloproliferative neoplasms
- PMID: 39145780
- DOI: 10.1007/s00277-024-05938-y
IRF4 dysregulation in chronic myelomonocytic leukemia: another brick in the wall of myelodysplastic/myeloproliferative neoplasms
References
-
- Chan O, Renneville A, Padron E (2021) Chronic myelomonocytic leukemia diagnosis and management. Leukemia 35:1552–1562. https://doi.org/10.1038/s41375-021-01207-3 - DOI - PubMed
-
- Khoury JD, Solary E, Abla O et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia 36:1703–1719. https://doi.org/10.1038/s41375-022-01613-1
-
- Arber DA, Orazi A, Hasserjian RP et al (2022) International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140:1200–1228. https://doi.org/10.1182/blood.2022015850 - DOI - PubMed - PMC
-
- Patnaik MM (2022) How I diagnose and treat chronic myelomonocytic leukemia. Haematologica 107:1503–1517. https://doi.org/10.3324/haematol.2021.279500 - DOI - PubMed - PMC
-
- Elmariah H, DeZern AE (2019) Chronic myelomonocytic leukemia: 2018 update to prognosis and treatment. Curr Hematol Malig Rep 14:154–163. https://doi.org/10.1007/s11899-019-00509-9 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources